Histogen’s lead product application is a Hair Stimulating Complex (HSC), intended to be a physician-administered therapeutic for alopecia (hair loss). HSC is anticipated to be a safe, minimally-invasive treatment that promotes new hair growth where existing treatments only reduce hair loss.
Through the same proprietary manufacturing process that produces CCM and HSC, a novel human extracellular matrix (hECM) is also created and holds potential as a biological matrix to replace or regenerate tissue for therapeutic applications including orthopedics, soft tissue augmentation and wound healing.
Histogen has developed a multipotent cell conditioned media (CCM) ingredient for skin care that harnesses the power of growth factors and other cell signaling molecules to support our epidermal stem cells, which renew skin throughout life. “Histogen has developed a next-generation regenerative cell technology, harnessing the power of growth factors and stem-cell signaling molecules for skin rejuvenation that complements Allergan’s flagship growth factor technology – TNS,” said Rahul...